Cargando…

Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction

Although the detrimental effects of diabetes mellitus/hyperglycemia have been observed in many liver disease models, the function and mechanism of hyperglycemia regulating liver‐resident macrophages, Kupffer cells (KCs), in thioacetamide (TAA)‐induced liver injury remain largely unknown. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Wei, Song, Zhou, Shun, Qiu, Jiannan, Shi, Chenyu, Liu, Rui, Zhou, Haoming, Lu, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004066/
https://www.ncbi.nlm.nih.gov/pubmed/31625631
http://dx.doi.org/10.1111/imcb.12297
_version_ 1783494653837836288
author Wang, Qi
Wei, Song
Zhou, Shun
Qiu, Jiannan
Shi, Chenyu
Liu, Rui
Zhou, Haoming
Lu, Ling
author_facet Wang, Qi
Wei, Song
Zhou, Shun
Qiu, Jiannan
Shi, Chenyu
Liu, Rui
Zhou, Haoming
Lu, Ling
author_sort Wang, Qi
collection PubMed
description Although the detrimental effects of diabetes mellitus/hyperglycemia have been observed in many liver disease models, the function and mechanism of hyperglycemia regulating liver‐resident macrophages, Kupffer cells (KCs), in thioacetamide (TAA)‐induced liver injury remain largely unknown. In this study, we evaluated the role of hyperglycemia in regulating NOD‐like receptor family pyrin domain‐containing 3 protein (NLRP3) inflammasome activation by inhibiting autophagy induction in KCs in the TAA‐induced liver injury model. Type I diabetes/hyperglycemia was induced by streptozotocin treatment. Compared with the control group, hyperglycemic mice exhibited a significant increase in intrahepatic inflammation and liver injury. Enhanced NLRP3 inflammasome activation was detected in KCs from hyperglycemic mice, as shown by increased gene induction and protein levels of NLRP3, cleaved caspase‐1, apoptosis‐associated speck‐like protein containing a caspase recruitment domain and interleukin‐1β, compared with control mice. NLRP3 inhibition by its antagonist CY‐09 effectively suppressed inflammasome activation in KCs and attenuated liver injury in hyperglycemic mice. Furthermore, inhibited autophagy activation was revealed by transmission electron microscope detection, decreased LC3B protein expression and p‐62 protein degradation in KCs isolated from TAA‐stressed hyperglycemic mice. Interestingly, inhibited 5′ AMP‐activated protein kinase (AMPK) but enhanced mammalian target of rapamycin (mTOR) activation was found in KCs from TAA‐stressed hyperglycemic mice. AMPK activation by its agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR) or mTOR signaling knockdown by small interfering RNA restored autophagy activation, and subsequently, inhibited NLRP3 inflammasome activation in KCs, leading to ultimately reduced TAA‐induced liver injury in the hyperglycemic mice. Our findings demonstrated that hyperglycemia aggravated TAA‐induced acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via inhibiting AMPK/mTOR‐mediated autophagy. This study provided a novel target for prevention of toxin‐induced acute liver injury under hyperglycemia.
format Online
Article
Text
id pubmed-7004066
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70040662020-02-11 Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction Wang, Qi Wei, Song Zhou, Shun Qiu, Jiannan Shi, Chenyu Liu, Rui Zhou, Haoming Lu, Ling Immunol Cell Biol Original Articles Although the detrimental effects of diabetes mellitus/hyperglycemia have been observed in many liver disease models, the function and mechanism of hyperglycemia regulating liver‐resident macrophages, Kupffer cells (KCs), in thioacetamide (TAA)‐induced liver injury remain largely unknown. In this study, we evaluated the role of hyperglycemia in regulating NOD‐like receptor family pyrin domain‐containing 3 protein (NLRP3) inflammasome activation by inhibiting autophagy induction in KCs in the TAA‐induced liver injury model. Type I diabetes/hyperglycemia was induced by streptozotocin treatment. Compared with the control group, hyperglycemic mice exhibited a significant increase in intrahepatic inflammation and liver injury. Enhanced NLRP3 inflammasome activation was detected in KCs from hyperglycemic mice, as shown by increased gene induction and protein levels of NLRP3, cleaved caspase‐1, apoptosis‐associated speck‐like protein containing a caspase recruitment domain and interleukin‐1β, compared with control mice. NLRP3 inhibition by its antagonist CY‐09 effectively suppressed inflammasome activation in KCs and attenuated liver injury in hyperglycemic mice. Furthermore, inhibited autophagy activation was revealed by transmission electron microscope detection, decreased LC3B protein expression and p‐62 protein degradation in KCs isolated from TAA‐stressed hyperglycemic mice. Interestingly, inhibited 5′ AMP‐activated protein kinase (AMPK) but enhanced mammalian target of rapamycin (mTOR) activation was found in KCs from TAA‐stressed hyperglycemic mice. AMPK activation by its agonist 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR) or mTOR signaling knockdown by small interfering RNA restored autophagy activation, and subsequently, inhibited NLRP3 inflammasome activation in KCs, leading to ultimately reduced TAA‐induced liver injury in the hyperglycemic mice. Our findings demonstrated that hyperglycemia aggravated TAA‐induced acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via inhibiting AMPK/mTOR‐mediated autophagy. This study provided a novel target for prevention of toxin‐induced acute liver injury under hyperglycemia. John Wiley and Sons Inc. 2019-11-19 2020-01 /pmc/articles/PMC7004066/ /pubmed/31625631 http://dx.doi.org/10.1111/imcb.12297 Text en © 2019 The Authors. Immunology & Cell Biology published by John Wiley & Sons Australia, Ltd on behalf of Australasian Society for Immunology Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Wang, Qi
Wei, Song
Zhou, Shun
Qiu, Jiannan
Shi, Chenyu
Liu, Rui
Zhou, Haoming
Lu, Ling
Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title_full Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title_fullStr Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title_full_unstemmed Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title_short Hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage NLRP3 inflammasome activation via the inhibition of AMPK/mTOR‐mediated autophagy induction
title_sort hyperglycemia aggravates acute liver injury by promoting liver‐resident macrophage nlrp3 inflammasome activation via the inhibition of ampk/mtor‐mediated autophagy induction
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004066/
https://www.ncbi.nlm.nih.gov/pubmed/31625631
http://dx.doi.org/10.1111/imcb.12297
work_keys_str_mv AT wangqi hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT weisong hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT zhoushun hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT qiujiannan hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT shichenyu hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT liurui hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT zhouhaoming hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction
AT luling hyperglycemiaaggravatesacuteliverinjurybypromotingliverresidentmacrophagenlrp3inflammasomeactivationviatheinhibitionofampkmtormediatedautophagyinduction